“…Germinal tumors are observed between 22 weeks and 32 weeks, and gliomas such as astrocytomas and glioblastomas are detected after 32 weeks. 22,23 On average, the gestational age at diagnosis is 27 weeks for teratomas, 21 weeks for hamartomas, and 34 weeks for gliomas. 11 No information is available on the relevant gestational age for the other types of CBTs.…”
Congenital brain tumors (CBTs), defined as tumors presenting within 60 days after birth, are extremely rare and account for only 0.5-1.9% of all pediatric brain tumors. Teratoma is the most common type of CBT, although there are many other poorly described forms. Prenatal diagnosis of CBT is often difficult and usually based on clinical characteristics and radiological findings with magnetic resonance imaging and ultrasonography. The prognosis of patients with CBT depends on the histopathological features of the tumor and its location. Even after several investigations have been performed, a clear direction for diagnosis and treatment of fetal intracranial tumors is still lacking. Further studies are thus needed to clarify its clinical characteristics and establish recommendations for management.
“…Germinal tumors are observed between 22 weeks and 32 weeks, and gliomas such as astrocytomas and glioblastomas are detected after 32 weeks. 22,23 On average, the gestational age at diagnosis is 27 weeks for teratomas, 21 weeks for hamartomas, and 34 weeks for gliomas. 11 No information is available on the relevant gestational age for the other types of CBTs.…”
Congenital brain tumors (CBTs), defined as tumors presenting within 60 days after birth, are extremely rare and account for only 0.5-1.9% of all pediatric brain tumors. Teratoma is the most common type of CBT, although there are many other poorly described forms. Prenatal diagnosis of CBT is often difficult and usually based on clinical characteristics and radiological findings with magnetic resonance imaging and ultrasonography. The prognosis of patients with CBT depends on the histopathological features of the tumor and its location. Even after several investigations have been performed, a clear direction for diagnosis and treatment of fetal intracranial tumors is still lacking. Further studies are thus needed to clarify its clinical characteristics and establish recommendations for management.
“…20 Fetal MRI might also provide useful information concerning tumor vascularity, hemorrhage, and assessment of intracranial anatomy (normal brain development and condition, hydrocephalus, midline shift, potential herniation) and for the detection of other congenital malformations. 2,9,29,35 Interestingly, ocular skew deviation found on fetal MRI has been described in one case and was considered a poor prognostic indicator linked with impending transtentorial herniation. 20…”
Section: Antenatal Diagnosismentioning
confidence: 99%
“…In cases where follow-up imaging is available, significant change in the size of the intracranial mass might be described, not only due to the tumor's reported tendency to increase rapidly, but sometimes due to the presence of hemorrhage as well (►Table 1). 2,4,9,29,35 It should be noted that there are no specific diagnostic criteria for congenital GBM. Other congenital brain tumors, as well as vascular malformations, infarctions, and primary hemorrhage should be included in the differential diagnosis since a definite diagnosis cannot be made only by prenatal sonography.…”
Section: Antenatal Diagnosismentioning
confidence: 99%
“…2,3 Most congenital GBMs are described as heterogeneous, typically solid masses, with varied signal intensity and with areas of hemorrhage and necrosis (►Table 2). 3,29,35,45 Necrosis with ringlike enhancement has been proposed as the major MRI criterion differentiating GBM from other intracranial tumors (especially anaplastic astrocytomas). It should be stressed though that the administration of contrast medium in fetal MRI is not recommended due to in utero retention and possible teratotoxicity.…”
Section: Antenatal Diagnosismentioning
confidence: 99%
“…The tumor is usually described as infiltrative, densely cellular, with high mitotic activity, increased MIB-1 rate, and with marked cytoplasmic and nuclear pleomorphism. 2,5,7,8,29,35 Despite the fact that it is considered highly invasive, exceptional cases without signs of infiltration have also been reported. 4,7,11 Areas of necrosis (zonal or pseudopalisading), as well as vascular proliferation and endothelial hyperplasia are typical findings.…”
Congenital glioblastoma multiforme is a rare tumor of the central nervous system with unique features. The existing evidence on its pathogenesis, genetic and molecular profile, special characteristics, treatment, and prognosis is reviewed. An increased number of antenatal diagnoses and prolonged survival for those individuals who can tolerate combined surgical resection and chemotherapy has been noted. The overall prognosis, however, remains poor. A better understanding of this unusual entity is important. Further research is needed to discern tumor's pathogenesis and natural history. This will likely lead to the development and implementation of treatment strategies that may decrease mortality and morbidity in these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.